baber/WOPTO huggingface dataset:
Patent NZ-580175-A (NZ)
Title: Apparatus and methods for correction of orthodontic malocclusions using sets of magnets bonded to the teeth
Inventor: DARENDELILER M
IPC: A61C7/08
Filed: 2008-03-05
Abstract: Disclosed is a sequential orthodontic appliance for repositioning at least one tooth from a first position to a corrected position where the surface of such one tooth has a first magnet bonded to it. The appliance comprises a thermoplastic body for engaging a plurality of teeth adjacent such one tooth, and at least one second magnet secured to the body at a selected location to interact with the first magnet. The first and second magnets are positioned relative to one another to urge, either in attractive or repulsive manner, such one tooth to move, reorient, and/or rotate in the desired manner, and wherein the body includes a space to allow only a limited movement of such one tooth from such first position to a second position which is not such corrected position.
Patent NZ-580737-A (NZ)
Title: Organic compound
Inventor: FAIRHURST ROBIN ALEC
IPC: C07D401/14
Filed: 2008-05-05
Abstract: Disclosed are substituted pyrazine compounds represented by general formula (I), wherein M1 and M2 are substituted pyrazines and the other substituents are defined within the specification. Examples of the compounds of formula (I) include N,N'-(1,1'-(1,4-phenylenebis(methylene))bis(azanediyl) bis(oxomethylene)bis(piperidine-4,1- diyl))bis(azanediyl) bis(iminomethylene)bis(3,5-diamino-6-chloropyrazine-2-carboxamide); N,N'-(1,1'-(1,4-phenylenebis(azanediyl))bis(oxomethylene)bis(piperidine-4,1-diyl))bis(azanediyl)bis(iminomethylene)bis(3,5-diamino-6-chloropyrazine-2-carboxamide); and N,N'-(1,1'-(cyclohexane-1,3-diylbis(methylene))bis(azanediyl)bis(oxomethylene)bis(piperidine-4,1-diyl))bis(azanediyl)bis (iminomethylene)bis(3,5-diamino-6-chloropyrazine-2-carboxamide); Also disclosed is the use of the compounds of formula (I) for treating cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, respiratory tract infection, lung carcinoma, xerostomia, keratoconjunctivitis or a disease treatable by the blockade of an epithelial sodium channel.
Patent NZ-580954-A (NZ)
Title: Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
Inventor: ANANTHARAMALAH GATTADAHALLI M
IPC: A61K38/00
Filed: 2006-04-18
Abstract: Provided is the use of a "D" or "L" peptide that comprises the amino acid sequence D-W-L-K-A-F-Y-D-K-F-F-E-K-F-K-E-F-F, or the retro form of said sequence in the manufacture of a medicament for mitigating one or more symptoms in a mammal of a condition selected from the group consisting of restenosis, emphysema, Paget's disease, Wegener's granulomatosis, central nervous system vasculitis (CNSV), Sjogren's syndrome, corneal ulcer, ulcerative colitis, reperfusion injury, ischemic reperfusion injury, a cancer, osteoarthritis, inflammatory bowel disease, allergic rhinitis, cachexia, Crohns' disease, dermatitis, asthma, erectile dysfunction, and macular degeneration. (62) Divided Out of 563187
Patent NZ-584453-A (NZ)
Title: Mechanical protective layer for solid dosage forms comprising two polyethylene glycols of differing molecular weight
Inventor: SOLER RANZANI LUIS
IPC: A61K9/20
Filed: 2008-10-03
Abstract: Disclosed is a mechanical protective layer for a dosage form comprising two or more plasticizer agents, where in a first plasticiser agent is a first polyethylene glycol (PEG) with an average molecular weight lower than 6,000 and a second plasticizer agent is a second polyethylene glycol different from the first polyethylene glycol, and wherein said mechanical protective layer is disposed on an enteric coated pellet. Further disclosed is the use of a mechanical protective layer which comprises two or more plasticizer agents, where in a first plasticiser agent is a first polyethylene glycol (PEG) with an average molecular weight lower than 6,000 and a second plasticizer agent is a second polyethylene glycol different from the first polyethylene glycol for the manufacture of solid dosage forms.
Patent NZ-584848-A (NZ)
Title: Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
Inventor: MERENICK BETHANY LYNN
IPC: A61K35/12
Filed: 2008-09-29
Abstract: Disclosed are methods and compositions for treating, ameliorating or preventing a disease or disorder in a subject by introducing into cells of the subject a therapeutic gene switch construct that controls expression of one or more therapeutic products.
Patent NZ-585272-A (NZ)
Title: Non-fat dry milk production processes for cheesemaking
Inventor: MERRILL RICHARD K
IPC: A23C9/18
Filed: 2008-10-03
Abstract: Methods of making a powdered dairy composition are disclosed. The methods include the steps of adding a sequestrant for calcium and rennet to a milk composition to make treated milk, and forming the treated milk into a milk powder. Powdered non-fat dry milk products are also disclosed. The products may include one or more milk proteins that have been enzymatically altered by chymosin, where the chymosin altered proteins are not coagulated. The products may also include one or more sequestants to bind calcium ions in the powdered product.
Patent NZ-585363-A (NZ)
Title: Synthetic analogues of neural regeneration peptides
Inventor: HARRIS PAUL WILLIAM RICHARD
IPC: C07K14/435
Filed: 2008-10-17
Abstract: Provided is synthetic neural regeneration peptides (NRP) compound, comprising a modified peptide domain APGR and/or a modified peptide domain RAGG and specified amino acid sequences. The peptides can be used to treat neurological disorders to repair damaged neurons, including amylotrophic lateral sclerosis, traumatic brain injury and diabetic neuropathy.
Patent NZ-588177-A (NZ)
Title: Methods involving ms4a12 and agents targeting ms4a12 for therapy, diagnosis and testing
Inventor: SAHIN UGUR
IPC: C12N15/113
Filed: 2009-03-30
Abstract: Disclosed are methods involving MS4A12 and agents targeting MS4A12 which are useful for therapy, diagnosis and testing of disease states, in particular cancer diseases. In particular, the invention relates to agents which reduce or inhibit expression or activity of MS4A12, compositions containing these agents, and methods for reducing, determining, or increasing the responsiveness of a cell towards EGF.
Patent NZ-589561-A (NZ)
Title: Downlight housing for use in a concrete slab, the housing having a pocket for a transformer associated with a downlight fitting
Inventor: BUTLER PHILLIP JOHN
IPC: F21V15/01
Filed: 2010-11-26
Abstract: Disclosed is a downlight housing for use in a concrete ceiling slab. The housing includes a hollow container for holding a downlight fitting and a transformer receiving receptacle connected to the container for holding a transformer for the downIight. The receptacle is formed integrally with the container. In use, both a downIight fitting and an associated transformer can be held in the one housing.
Patent NZ-590603-A (NZ)
Title: Method for preparation of lactic acid bacterium having anti-allergic activity comprising culturing bacterium in casein hydrolysate
Inventor: FUJIWARA SHIGERU
IPC: A61K35/747
Filed: 2006-01-04
Abstract: Disclosed is a method for preparing a lactic acid bacterium having an anti-allergic activity and/or having an activity of stimulating the production of IL-12 comprising culturing the lactic acid bacterium in a medium containing casein hydrolysate, wherein the casein hydrolysate is pancreatin hydrolysate.
Patent NZ-593216-A (NZ)
Title: Resectoscope with movable field of view
Inventor: LARSEN DANE M
IPC: A61B10/04
Filed: 2007-04-05
Abstract: A surgical instrument has a shaft with a proximal end and a blunt enclosed distal end with an optically transparent window 702. A viewing instrument channel is provided within the shaft which accommodates a viewing instrument 802 with a viewing end inserted from the proximal end and movable between first and second positions. When the viewing instrument is in the first position (Fig 13) within the shaft the viewing end is on the distal side of a working area within which resection can occur and proximate to the optically transparent window of the distal and so as to provide an unobstructed view external of the blunt enclosed distal end. When the viewing instrument is in the second position (Fig 14) within the shaft the viewing end is on the proximal side of the working area and provides a view of the working area.
Patent NZ-594885-A (NZ)
Title: Growing algae and cyanobacteria in an apparatus with a first light guide for concentrating light wherein the apparatus is capable as acting as a second light guide
Inventor: FALBER ALEXANDER
IPC: A01G33/00
Filed: 2010-01-29
Abstract: 594885 Disclosed is an algae containment apparatus (50) for growing an alga or a cyanobacterium, the algae containment apparatus (50) including a first light guide (76). The first light guide (76) is a luminescent light guide comprising a first luminescent material and guides light to the algae containment apparatus (50) underneath the first light guide (76). The first luminescent material emits visible light suitable for growing the alga or cyanobacterium or emits visible light suitable for absorption by a second luminescent material. The algae containment apparatus (50) is capable of forming a second light guide.
Patent NZ-596118-A (NZ)
Title: Disaccharin, difumaric acid, di-1-hydroxy-2-naphthoic acid and mono-benzoic acid salts of 4- (dimethylamino)butyl 2- (4- ( (2-amino-4-methyl-6- (pentylamino) pyrimidin- 5 -yl) methyl) phenyl)acetate
Inventor: BENNETT NICHOLAS JAMES
IPC: A61K31/505
Filed: 2010-05-20
Abstract: Disclosed herein is a disaccharin, difumaric acid, di-l-hydroxy-2-naphthoic acid or mono-benzoic acid salt of 4-(dimethyl amino)butyl-2-(4-((2-amino-4-methyl-6-(pentylamino)pyrimidin-5yl)methyl)phenyl)acetate (compound (I)), compositions comprising said compound, processes for its preparation and uses thereof. Said compound/composition is useful in the treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis B, hepatitis C, HIV, HPV, bacterial infections or dermatosis.
Patent NZ-596252-A (NZ)
Title: A method for detection of human papillomavirus (hpv) type
Inventor: JENKINS ANDREW
IPC: C12N15/11
Filed: 2010-04-22
Abstract: 596252 Disclosed is a method for detecting and/or typing and/or quantitation simultaneously the presence of HPV 18, 52, 59, 39, 51, 56, 66, 16, 45, 58, 31, 33 and 35 in a biological sample, the method comprising the following four parallel reactions: Reaction 1: a) amplification of the nucleic acid fragments of HPV 18, 52 and 59 in the presence of: (i) a nucleic acid polymerase (ii) a forward PCR primer with an oligonucleotide sequence of SEQ ID NO:1, (iii) a reverse PCR primer with an oligonucleotide sequence of SEQ ID NO:2, (iv) a probe with an oligonucleotide sequence of SEQ ID NO:7, 8 and 9, labelled with a fluorophore and a quencher molecule and b) detection of a change of fluorescence the wavelength thereof determining the HPV type 18, 52 and 59; Reaction 2: a) amplification of the nucleic acid fragments of HPV 39, 51, 56 and 66 in the presence of: (i) a nucleic acid polymerase (ii) a forward PCR primer with an oligonucleotide sequence of SEQ ID NO:1, (iii) a reverse PCR primer with an oligonucleotide sequence of SEQ ID NO:3, (iv) a probe with an oligonucleotide sequence of SEQ ID NO: 10, 11, 12 and 13, labelled with a fluorophore and a quencher molecule and b) detection of a change of fluorescence the wavelength thereof determining the HPV type 39,51,56 and 66; Reaction 3: a) amplification of the nucleic acid fragments of HPV 16, 45 and 58 in the presence of: (i) a nucleic acid polymerase (ii) a forward PCR primer with an oligonucleotide sequence of SEQ ID NO:1, (iii) a reverse PCR primer with an oligonucleotide sequence of SEQ ID NO:4, (iv) a probe with an oligonucleotide sequence of SEQ ID NO:14, 15 and 16, labelled with a fluorophore and a quencher molecule and b) detection of a change of fluorescence the wavelength thereof determining the HPV type 16, 45 and 58; Reaction 4: a) amplification of the nucleic acid fragments of HPV 31, 33 and 35 and internal control in the presence of: (i) a nucleic acid polymerase (ii) a forward PCR primer with an oligonucleotide sequence of SEQ ID NO:1, (iii) a reverse PCR primer with an oligonucleotide sequence of SEQ ID NO:5, (iv) a probe with an oligonucleotide sequence of SEQ ID NO:17, 18, 19 and 20, labelled with a fluorophore and a quencher molecule, and (v) internal control, and b) detection of a change of fluorescence the wavelength thereof determining the HPV type 31,33 and 35 and internal control.
Patent NZ-596875-A (NZ)
Title: Depolymerization of organic and non-organic waste materials into useful products
Inventor: ADAMS TERRY N
IPC: C10G1/00
Filed: 2006-09-29
Abstract: Abstract - 596875 Disclosed is a process for producing a fuel from a carbon containing feedstock comprising at least one of plastics, rubber, foams and elastomers, said process comprising: preparing a slurry from the feedstock; depolymerising the slurry by heating sufficiently (typically in the range of about 135°C to about 420°C) to reduce organic solids to liquids to form a composition comprising at least one solid material in a liquid mixture; separating said at least one solid material including inorganics from the liquid mixture; mixing water with the liquid mixture; hydrolysing the liquid mixture by heating at a pressure above the saturation pressure of water in the liquid mixture (typically at a temperature in a range of about 150°C to about 400°C) to produce a reacted feed; and deriving a hydrocarbon fuel from reacted feed. Also disclosed is a process for producing fuel from a feed stock containing at least one of shredder residue, tires, plastics or rubber, comprising: preparing a slurry including a liquid to form a process stream from the feedstock; depolymerizing the process stream at a temperature in the range of about 135°C to 420°C; separating at least one undissolved solid material from the process stream after depolymerising; adding water to the process stream; hydrolyzing the depolymerized and separated process stream at a temperature in the range of about 150°C to about 400°C and a pressure above the saturation pressure of water in the process stream at said hydrolysis temperature; flash reducing the pressure of the process stream after hydrolysing to recover vapours and heat, including steam; separating and removing solids from the process stream after reducing the pressure; separating water from the process stream after reducing the pressure; and diverting the process stream for use as a fuel. Further disclosed is a process for converting animal processing waste (such as animal offal) into at least one useful material, comprising: preparing a slurry from the animal processing waste; depolymerizing the slurry at a first temperature sufficient to breakdown proteinaceous materials in the slurry and drive off ammonia at a pressure above the saturation pressure of water in the slurry; separating at least one solid material including inorganics from the slurry to produce a liquid mixture; hydrolyzing the liquid mixture at a second, higher temperature ranging from about 150°C to about 330°C at a pressure of at least at the saturation pressure of water in the liquid to produce a reacted feed comprising at least one reacted so lid product, and at least one reacted liquid product comprising floatable organic materials and water containing solubles; separating the at least one reacted solid product and the water containing solubles, from the at least one reacted liquid product in the reacted feed; and converting the at least one reacted liquid product into at least one of hydrocarbon oils, fuel gas, and carbon.
Patent NZ-598379-A (NZ)
Title: A clean-in-place device for a milk conveying system using steam and control means
Inventor: BOSMA EPKE
IPC: A01J7/02
Filed: 2010-10-12
Abstract: A clean-in-place device for a milk conveying system. The milk conveying system comprises at least two separate areas A, B with surfaces difficult to clean. The clean-in-place device comprises a steam source 24, steam passages 25, 26 extending between the steam source 24 and a respective outlet opening 25a, 26a from which it is possible to supply steam to the areas A, B of the milk conveying system and control means 7, 27 adapted to control the supply of steam from the steam source 24 to the areas A, B of the milk conveying system.
Patent NZ-599030-A (NZ)
Title: Drive mechanism for a drug delivery device
Inventor: VEASEY ROBERT
IPC: A61M5/315
Filed: 2010-09-29
Abstract: A first input member (6) and a second input member (7) are arranged along a first axis (4) and coupled in such a manner that a movement of the first input member along the first axis is converted into a rotational movement of the second input member with respect to the body (1). A first output member (8) and a second output member (9) are arranged along a second axis (5) and coupled in such a manner that a rotational movement of the first output member is converted into a movement of the second output member along the second axis with respect to the body. The second input member and the first output member are releasably rotationally coupled.
Patent NZ-599120-A (NZ)
Title: Kit for separation of biological fluids
Inventor: LAVI GILAD
IPC: A61B5/15
Filed: 2010-10-08
Abstract: 599120 For containing a biological fluid and draining a constituent of the biological fluid, a kit includes a barrel, a piston assembly, a removable element, which is configured to move the piston assembly, a drainage element, which interacts with the piston assembly, and an interacting element, which interacts with the piston assembly. The kit allows for fluid separation without risk of contamination from the biological fluid itself or contamination of the biological fluid itself. Further, the kit offers the advantage of involving no needles or other sharp elements.
Patent NZ-608239-A (NZ)
Title: Aqueous drug delivery system comprising off - flavor masking agent
Inventor: REED KYLE A
IPC: A23L27/00
Filed: 2011-09-13
Abstract: Disclosed herein is a water stable pharmaceutical composition comprising a therapeutic agent such as aspirin, naproxen sodium, acetaminophen, and ibuprofen; and an off-flavour masking agent comprising a cyclic oligosaccharide such as cyclodextrin; in a water stable pharmaceutically acceptable gel matrix; wherein the water stable pharmaceutically acceptable gel matrix comprises a non-ion-specific gel comprising a polysaccharide such as gellan.
Patent NZ-609076-A (NZ)
Title: Methods for radiolabelling macromolecules
Inventor: STEPHENS ROSS WENTWORTH
IPC: B82Y5/00
Filed: 2009-04-23
Abstract: Disclosed is a method for preparing a radiolabeled macromolecule, the method comprising contacting the macromolecule poly-lysine with a carbon encapsulated nanoparticle composite having a radioactive particulate core in an aqueous medium comprising a pH selected to promote short-range attractive forces between the nanoparticles and the macromolecule by attenuating repulsive electrostatic forces, wherein the carbon encapsulated nanoparticle composite is a carbon encapsulated 99mTc, 113mIn, 111In, 198Au, 64Cu, 213Bi, 57Co, 51Cr, 165Dy, 169Er, 59Fe, 153Gd, 166Ho, 177Lu, 103Pd, 81Rb, 82Rb, 186Re, 188Re, 75Se, 153Sm, 117mSn, 89Sr, 201Th, 90Y, or 169Y nanoparticle having a diameter of 10 to 500 nanometres.
Patent NZ-612038-A (NZ)
Title: Antibody against the csf-1r
Inventor: HAEGEL HÉLÈNE
IPC: A61P35/00
Filed: 2012-02-07
Abstract: Disclosed is an isolated, recombinant or purified antibody that specifically binds to CSF-1 R, wherein said antibody comprises: (i) (a) first variable region consisting in SEQ 10 NO:42, and (b) a second variable region consisting in SEQ ID NO:44; or (ii) (a) first variable region consisting in SEQ 10 NO:43, and (b) a second variable region consisting in SEQ ID NO:45; or (iii) (a) first variable region consisting in SEQ 10 NO:42, and (b) a second variable region consisting in SEQ ID NO:46.
Patent NZ-618958-A (NZ)
Title: Compositions for depositing agents using highly volatile silicone solvents
Inventor: COOPER EUGENE R
IPC: A61Q5/12
Filed: 2012-06-18
Abstract: Disclosed herein are compositions comprising a volatile silicone solvent, a germicide selected from the group consisting of alky quaternary ammonium germicides, lauric acid and undecylenic acid and a polydimethylsiloxane having a viscosity of 50,000 cSt or greater. Compositions of the invention can advantageously be applied to broken skin such as abrasions without pain and touching. Agents can thereby be delivered to the skin in a few seconds leaving behind a thin antimicrobial film.
Patent NZ-623884-A (NZ)
Title: Fine dry particulate adenosine compositions and topical formulations including the same
Inventor: MANSOURI ZAHRA
IPC: A61K31/7076
Filed: 2012-08-16
Abstract: Provided are fine dry particulate compositions comprising adenosine in association with nanoporous calcium particles, for example via entrapment of adenosine in the pores of the particles and/or ionic binding and/or non-covalent binding of adenosine to the surface of the particles. Also provided are topical formulations which include the particulate adenosine compositions.
Patent NZ-624158-A (NZ)
Title: A spear
Inventor: B OCONNOR
IPC: F41B13/10
Filed: 2013-01-31
Abstract: Disclosed is a spear (1) or part thereof which allows easy removal of the spear (1) once a fish has been speared. The spear (1) comprises a shaft (2) with a pointed end; a barb (3) adjacent the pointed end (5); a barb biasing means (6); and a barb moving means (9) such as a length of wire or cord. The spear (1) is formed such that the biasing means (6) biases the barb to angle outwardly from the shaft (2). The barb moving means (9) can be manipulated to overcome the biasing means to cause the barb (3) to move from a position angled away from the shaft (2) to a position substantially against the shaft (2) in order to facilitate withdrawal of the spear (1) from a speared target.
Patent NZ-624517-A (NZ)
Title: A matrix-metalloproteinase (mmp) inhibitory extract and methods of use thereof
Inventor: GREGOR AARON STEINHORN
IPC: C07C39/00
Filed: 2014-05-06
Abstract: Disclosed is a cometic skin care product comprising a therapeutically effective amount of a honey extract comprising phenolic compounds comprising an MMP inhibitory phenolic extract and the cosmetic skin care product also comprising a mixture of at least ethanol and water to reduce the loss of skin elasticity and therefore the formation of wrinkles. Also disclosed is a method of producing cosmetic skin care product comprising a honey extract rich in phenolic compounds, comprising an MMP inhibitory phenolic extract including the steps of: (a) mixing a honey selected from the genus Leptospermum, Knightia, Kunzea and combinations thereof with ethanol; (b) separating the mixture to substantially remove a saccharide concentrated first phase from a second phase including ethanol, water and one or more MMP inhibitory phenolic compounds; (c) conducting a further separation step to increase the phenolic compound concentration by reducing the ethanol and/or water concentration; and (d) collecting the resulting phenolic compound concentrate.
Patent NZ-625004-A (NZ)
Title: Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases
Inventor: LEE SANG-HO
IPC: A61P3/06
Filed: 2012-11-28
Abstract: Provided is the use of a combination of (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({ 2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl} methyl)-4-methyl-1,3-oxazolidin-2-one (anacetrapib) and a calcium channel blocker or a fibrate for the prevention or treatment of hypertriglyceridemia or hypertriglyceridemia-associated diseases. A preferred calcium channel blocker is amlodipine. A preferred fibrate is fenofibrate.